Home » Organoid » Join us at Neuroscience 2026 – Comprehensive Solutions for Translational CNS Discovery

Join us at Neuroscience 2026 – Comprehensive Solutions for Translational CNS Discovery

Lambda Biologics will be exhibiting at Neuroscience 2026, the Society for Neuroscience’s annual meeting and the world’s largest gathering of brain scientists. Under the theme Comprehensive Solutions for Translational CNS Discovery, we will present our human neural and retinal organoid models, generation kits and stage-matched media, and patient-derived iPSC services for custom disease modelling. Join us to explore human-relevant models built to bring CNS research closer to the clinic.

  • 14 – 18 November 2026
  • Walter E. Washington Convention Center, Washington, D.C., USA
  • Lambda Biologics Booth: 2306

Human-relevant models for CNS discovery

Neurological drug development has one of the highest attrition rates in medicine, in part because animal models and 2D cultures capture little of the cellular diversity, architecture and patient genetics of the human brain and retina.

Lambda Biologics’ brain organoid platform brings these elements together in 3D human tissue, enabling:

  • Neurodevelopmental and neurodegenerative disease modelling, including Parkinson’s disease
  • Region-specific models: cerebral, midbrain, striatal and retinal organoids
  • Compound screening, neurotoxicity and efficacy testing in human tissue
  • Patient-specific models from iPSCs carrying disease-relevant genotypes
  • Animal-free data aligned with the shift towards New Approach Methodologies (NAMs)

What We Are Showcasing at Neuroscience 2026

3D Neural & Retinal Organoid Models

Cerebral, midbrain, striatal and retinal organoids that recapitulate region-specific human cell types and architecture, for disease modelling, screening and safety studies.

Generation Kits & Stage-Matched Media

Ready-to-use kits and media optimised for each stage of organoid differentiation, so labs can establish reproducible neural and retinal organoid cultures in house.

Patient-Derived iPSC & Custom Disease Modelling

iPSC generation from patient samples and custom disease models built around your target, genotype and readouts, from Parkinson’s disease to rare neurological and retinal disorders.

Meet Lambda Biologics at Neuroscience 2026

Working on CNS drug discovery, neurodegeneration or retinal disease? Visit us at Booth No. 2306, or book a meeting in advance to explore collaboration opportunities.

Subscribe
to the latest updates in the newsletter

Related Solutions

  • Disease Modeling
  • Oncology
  • Organoid
  • Cosmetics
  • OECD TG
  • Zebrafish
  • Bioinfomatics
  • Live&3D Imaging
  • Molecular biology
  • Spatial Biology
Technical Service

Next Articles

There are no further posts.

Thank you for your submission.

Our team has received your request and will get back to you shortly with tailored workflows and relevant case studies for your ADC efficacy and toxicity evaluation needs.
If you do not receive our confirmation email, kindly check your spam or junk folder.

Thank you for your interest

You can now download the file.

Connect with Us